Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?

Chen F, Li DY, Zhang B, Sun JY, Sun F, Ji X, Qiu JC, Parker RB, Laizure SC, Xu J.

Drug Metab Rev. 2018 Aug;50(3):369-397. doi: 10.1080/03602532.2018.1497645. Epub 2018 Sep 16.

PMID:
30221555
2.

Clinical implications of genetic variation in carboxylesterase drug metabolism.

Chen F, Zhang B, Parker RB, Laizure SC.

Expert Opin Drug Metab Toxicol. 2018 Feb;14(2):131-142. doi: 10.1080/17425255.2018.1420164. Epub 2018 Jan 4. Review.

PMID:
29264996
3.

Comparison of caffeine disposition following administration by oral solution (energy drink) and inspired powder (AeroShot) in human subjects.

Laizure SC, Meibohm B, Nelson K, Chen F, Hu ZY, Parker RB.

Br J Clin Pharmacol. 2017 Dec;83(12):2687-2694. doi: 10.1111/bcp.13389. Epub 2017 Sep 5.

4.

Why Diversity and Inclusion Are Critical to the American College of Emergency Physicians' Future Success.

Parker RB, Stack SJ, Schneider SM; ACEP Diversity Summit 2016 Attendees.

Ann Emerg Med. 2017 Jun;69(6):714-717. doi: 10.1016/j.annemergmed.2016.11.030. Epub 2017 Jan 27. No abstract available.

PMID:
28139303
5.

The Importance of Research and Scholarly Activity in Pharmacy Training.

Deal EN, Stranges PM, Maxwell WD, Bacci J, Ashjian EJ, DeRemer DL, Kane-Gill SL, Norgard NB, Dombrowski L, Parker RB; American College of Clinical Pharmacy.

Pharmacotherapy. 2016 Dec;36(12):e200-e205. doi: 10.1002/phar.1864. Epub 2016 Nov 25.

PMID:
27885711
6.

Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI-MS/MS and clinical application.

Chen F, Hu ZY, Parker RB, Laizure SC.

Biomed Chromatogr. 2017 Jun;31(6). doi: 10.1002/bmc.3900. Epub 2017 Jan 4.

7.

A psychometric evaluation of the Gender Bias in Medical Education Scale.

Parker RB, Parker PD, Larkin T, Cockburn J.

BMC Med Educ. 2016 Sep 29;16(1):251.

8.

Student Pharmacists' Perceptions of a Composite Examination in Their First Professional Year.

McDonough SL, Alford EL, Finks SW, Parker RB, Chisholm-Burns MA, Phelps SJ.

Am J Pharm Educ. 2016 Feb 25;80(1):4. doi: 10.5688/ajpe8014.

9.

Enhanced Cross-Linking of Diazirine-Modified Sialylated Glycoproteins Enabled through Profiling of Sialidase Specificities.

McCombs JE, Zou C, Parker RB, Cairo CW, Kohler JJ.

ACS Chem Biol. 2016 Jan 15;11(1):185-92. doi: 10.1021/acschembio.5b00775. Epub 2015 Nov 16.

10.

Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors.

Patnaik A, Weiss GJ, Leonard JE, Rasco DW, Sachdev JC, Fisher TL, Winter LA, Reilly C, Parker RB, Mutz D, Blaydorn L, Tolcher AW, Zauderer M, Ramanathan RK.

Clin Cancer Res. 2016 Feb 15;22(4):827-36. doi: 10.1158/1078-0432.CCR-15-0431. Epub 2015 Oct 7.

11.

Stroke associated with discontinuation of warfarin therapy for atrial fibrillation.

Spivey CA, Liu X, Qiao Y, Mardekian J, Parker RB, Phatak H, Masseria C, Kachroo S, Abdulsattar Y, Wang J.

Curr Med Res Opin. 2015 Nov;31(11):2021-9. doi: 10.1185/03007995.2015.1082995. Epub 2015 Sep 21.

PMID:
26390258
12.

Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation.

Spivey CA, Qiao Y, Liu X, Mardekian J, Parker RB, Phatak H, Claflin AB, Kachroo S, Abdulsattar Y, Chakrabarti A, Wang J.

J Manag Care Spec Pharm. 2015 Jul;21(7):596-606.

13.

Effects of alcohol on human carboxylesterase drug metabolism.

Parker RB, Hu ZY, Meibohm B, Laizure SC.

Clin Pharmacokinet. 2015 Jun;54(6):627-38. doi: 10.1007/s40262-014-0226-2.

14.

Discontinuation/Interruption of Warfarin Therapy in Patients with Non-Valvular Atrial Fibrillation.

Wang J, Qiao Y, Spivey CA, Liu X, Phatak H, Mardekian J, Claflin AB, Kachroo S, Abdulsatter Y, Parker RB.

Value Health. 2014 Nov;17(7):A763. doi: 10.1016/j.jval.2014.08.272. Epub 2014 Oct 26. No abstract available.

15.

Health Care Utilization and Costs After Warfarin Discontinuation Among Patients with Non-Valvular Atrial Fibrillation.

Wang J, Qiao Y, Spivey CA, Liu X, Phatak H, Mardekian J, Claflin AB, Kachroo S, Abdulsatter Y, Parker RB.

Value Health. 2014 Nov;17(7):A756. doi: 10.1016/j.jval.2014.08.230. Epub 2014 Oct 26. No abstract available.

16.

Physiologically based pharmacokinetic modeling of impaired carboxylesterase-1 activity: effects on oseltamivir disposition.

Hu ZY, Edginton AN, Laizure SC, Parker RB.

Clin Pharmacokinet. 2014 Sep;53(9):825-36. doi: 10.1007/s40262-014-0160-3. Erratum in: Clin Pharmacokinet. 2014 Oct;53(10):959.

PMID:
25103325
17.

Identification of alcohol-dependent clopidogrel metabolites using conventional liquid chromatography/triple quadrupole mass spectrometry.

Hu ZY, Laizure SC, Herring VL, Parker RB.

Rapid Commun Mass Spectrom. 2014 Jun 15;28(11):1285-92. doi: 10.1002/rcm.6901.

18.

Throwing a curveball: the impact of instructor decisions regarding poorly performing test questions.

Phelps SJ, McDonough SK, Parker RB, Finks SW.

Am J Pharm Educ. 2013 Nov 12;77(9):204. doi: 10.5688/ajpe779204. No abstract available.

19.

Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.

Laizure SC, Parker RB, Herring VL, Hu ZY.

Drug Metab Dispos. 2014 Feb;42(2):201-6. doi: 10.1124/dmd.113.054353. Epub 2013 Nov 8.

20.

Preparing clinical pharmacy scientists for careers in clinical/translational research: can we meet the challenge?: ACCP Research Affairs Committee Commentary.

Parker RB, Ellingrod V, DiPiro JT, Bauman JL, Blouin RA, Welage LS.

Pharmacotherapy. 2013 Dec;33(12):e337-46. doi: 10.1002/phar.1348. Epub 2013 Sep 30.

PMID:
24114730
22.

The role of human carboxylesterases in drug metabolism: have we overlooked their importance?

Laizure SC, Herring V, Hu Z, Witbrodt K, Parker RB.

Pharmacotherapy. 2013 Feb;33(2):210-22. doi: 10.1002/phar.1194. Review.

23.
24.

Photocrosslinking approaches to interactome mapping.

Pham ND, Parker RB, Kohler JJ.

Curr Opin Chem Biol. 2013 Feb;17(1):90-101. doi: 10.1016/j.cbpa.2012.10.034. Epub 2012 Nov 10. Review.

26.

Sialidase specificity determined by chemoselective modification of complex sialylated glycans.

Parker RB, McCombs JE, Kohler JJ.

ACS Chem Biol. 2012 Sep 21;7(9):1509-14. Epub 2012 Jun 26.

27.

In vivo information-guided prediction approach for assessing the risks of drug-drug interactions associated with circulating inhibitory metabolites.

Hu ZY, Parker RB, Laizure SC.

Drug Metab Dispos. 2012 Aug;40(8):1487-94. doi: 10.1124/dmd.112.045799. Epub 2012 May 4.

28.

Effects of paroxetine on the pharmacokinetics and pharmacodynamics of immediate-release and extended-release metoprolol.

Parker RB, Soberman JE.

Pharmacotherapy. 2011 Jul;31(7):630-41. doi: 10.1592/phco.31.7.630.

PMID:
21923449
29.

Paralytic ileus associated with use of diltiazem.

Wright S, Ali M, Robinson A, Ramanathan K, Parker RB.

Am J Health Syst Pharm. 2011 Aug 1;68(15):1426-9. doi: 10.2146/ajhp100582.

PMID:
21785032
30.

A comparison of the metabolism of clopidogrel and prasugrel.

Laizure SC, Parker RB.

Expert Opin Drug Metab Toxicol. 2010 Nov;6(11):1417-24. doi: 10.1517/17425255.2010.519334. Epub 2010 Sep 14. Review.

PMID:
20839914
31.

Regulation of intracellular signaling by extracellular glycan remodeling.

Parker RB, Kohler JJ.

ACS Chem Biol. 2010 Jan 15;5(1):35-46. doi: 10.1021/cb9002514. Review.

32.

The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions.

Parker RB, Laizure SC.

Drug Metab Dispos. 2010 Feb;38(2):317-22. doi: 10.1124/dmd.109.030056. Epub 2009 Nov 17.

33.

Pharmacodynamic evaluation of the cardiovascular effects after the coadministration of cocaine and ethanol.

Laizure SC, Parker RB.

Drug Metab Dispos. 2009 Feb;37(2):310-4. doi: 10.1124/dmd.108.023531. Epub 2008 Nov 12.

34.

Tissue 65Zinc translocation in a rat model of chronic aldosteronism.

Selektor Y, Parker RB, Sun Y, Zhao W, Bhattacharya SK, Weber KT.

J Cardiovasc Pharmacol. 2008 Apr;51(4):359-64. doi: 10.1097/FJC.0b013e318165b96e.

35.

A comprehensive approach to faculty development.

Boucher BA, Chyka PJ, Fitzgerald WL, Hak LJ, Miller DD, Parker RB, Phelps SJ, Wood GC, Gourley DR.

Am J Pharm Educ. 2006 Apr 15;70(2):27.

36.

P-glycoprotein modulates aldosterone plasma disposition and tissue uptake.

Parker RB, Yates CR, Laizure SC, Weber KT.

J Cardiovasc Pharmacol. 2006 Jan;47(1):55-9.

PMID:
16424786
37.

A pharmacodynamic model of the effects of controlled-onset extended-release verapamil on 24-hour ambulatory blood pressure.

Lima JJ, Beasley BN, Parker RB, Johnson JA.

Int J Clin Pharmacol Ther. 2005 Apr;43(4):187-94.

PMID:
15966465
38.

Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans.

Parker RB, Yates CR, Soberman JE, Laizure SC.

Pharmacotherapy. 2003 Aug;23(8):979-87.

PMID:
12921244
39.

Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases.

Laizure SC, Mandrell T, Gades NM, Parker RB.

Drug Metab Dispos. 2003 Jan;31(1):16-20.

PMID:
12485948
40.

Providing telephone advice from the emergency department.

Proctor JH, Hirshberg AJ, Kazzi AA, Parker RB; American College of Emergency Physicians.

Ann Emerg Med. 2002 Aug;40(2):217-9.

PMID:
12140502
41.

CHF: circulatory homeostasis gone awry.

Weber KT, Burlew BS, Davis RC, Newman KP, D'Cruz IA, Hawkins RG, Wall BM, Parker RB.

Congest Heart Fail. 2002 Jan-Feb;8(1):37-48. Review.

42.

Repair of diaphyseal femoral fractures in cats using interlocking intramedullary nails: 12 cases (1996-2000).

Larin A, Eich CS, Parker RB, Stubbs WP.

J Am Vet Med Assoc. 2001 Oct 15;219(8):1098-104.

PMID:
11700708
43.

Effects of COER-verapamil on circadian pattern of forearm vascular resistance and blood pressure.

Nguyen BN, Parker RB, Noujedehi M, Sullivan JM, Johnson JA.

J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1480-7.

PMID:
11185670
44.

Use of Filgrastim for Ticlopidine Induced Neutropenia Following Coronary Stenting.

Nguyen BN, Parker RB, Geraci SA.

J Invasive Cardiol. 1998 May;10(4):226-228. No abstract available.

PMID:
10973347
45.

Comparative effects of sodium bicarbonate and sodium chloride on reversing cocaine-induced changes in the electrocardiogram.

Parker RB, Perry GY, Horan LG, Flowers NC.

J Cardiovasc Pharmacol. 1999 Dec;34(6):864-9.

PMID:
10598131
46.

Cocaethylene formation in rat, dog, and human hepatic microsomes.

Song N, Parker RB, Laizure SC.

Life Sci. 1999;64(23):2101-8.

PMID:
10372652
47.

Radiographic evaluation of elbow joints before and after surgery in dogs with possible fragmented medial coronoid process.

Wosar MA, Lewis DD, Neuwirth L, Parker RB, Spencer CP, Kubilis PS, Stubbs WP, Murphy ST, Shiroma JT, Stallings JT, Bertrand SG.

J Am Vet Med Assoc. 1999 Jan 1;214(1):52-8.

PMID:
9887940
48.

Effect of radiographic positioning on interpretation of cubital joint congruity in dogs.

Murphy ST, Lewis DD, Shiroma JT, Neuwirth LA, Parker RB, Kubilis PS.

Am J Vet Res. 1998 Nov;59(11):1351-7.

PMID:
9829389
49.

Evaluation of dose-dependent pharmacokinetics of cocaethylene and cocaine in conscious dogs.

Parker RB, Laizure SC, Williams CL, Mandrell TD, Lima JJ.

Life Sci. 1998;62(4):333-42.

PMID:
9450505
50.

Osteosarcoma following total hip arthroplasty in a dog.

Murphy ST, Parker RB, Woodard JC.

J Small Anim Pract. 1997 Jun;38(6):263-7.

PMID:
9200118

Supplemental Content

Loading ...
Support Center